Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials
Author/Authors :
Gilles R Dagenais، نويسنده , , Janice Pogue، نويسنده , , Kim Fox، نويسنده , , Marteen L Simoons، نويسنده , , Salim Yusuf، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2007
Pages :
8
From page :
581
To page :
588
Abstract :
Background
Angiotensin-converting-enzyme (ACE) inhibitors reduce cardiovascular mortality and morbidity in patients with heart failure or left ventricular systolic dysfunction (LVSD). Three large trials have assessed the effect of ACE inhibitors in stable
